Arkansas puts a dollar floor under the right to external review

The $500 threshold

This is the first thing to check, because it decides whether there is a path at all. The Arkansas Insurance Department describes external review as an independent review of claims for benefits to see whether they are medically necessary or experimental and investigational, and states that the requested benefit must be at least $500 for external review to apply. A denial below that line is not an external-review matter, however wrong it may be.

Four months, filed with the Commissioner

The window runs four months from the date of receipt of a notice of adverse determination or final adverse determination, and the request goes to the Commissioner rather than to the carrier. Rule 76 applies the same four months to the experimental-or-investigational track, so there is only one deadline to remember whichever kind of denial you are facing.

• Filing window: 4 months from receipt of the adverse or final adverse determination.
• Same 4 months where the denial is based on experimental or investigational status.
• Filed with: the Commissioner.
• Commissioner forwards a copy to the health carrier within 1 business day.

What the Commissioner does first

The state does not sit on the request. Within one business day after the date of receipt of a request for external review, the Commissioner sends a copy of the request to the health carrier, which is what starts the carrier's side of the process running. A request that arrives complete therefore reaches the insurer almost immediately.

Which denials the process is for

Two categories, and they are the same two that dominate this kind of dispute nationally: whether the treatment or service is medically necessary, and whether it is experimental or investigational. A refusal grounded in a plain contractual exclusion, or a purely administrative rejection, is a different conversation and belongs with the carrier or with a complaint to the Department.

Exhaust the internal appeal first

Arkansas frames external review as what becomes available once the carrier's internal appeal process has been exhausted. The Department's guidance also makes the practical point that the information about the appeals process will have arrived with the denial letter or the explanation of benefits — which is the document to read before assuming a national timeline applies.

Where the rule comes from

Rule 76 is the operative instrument, and it is promulgated under a stack of enabling provisions: Ark. Code Ann. 23-61-108 on the Commissioner's rulemaking, 23-66-205 and 23-66-207 within the trade practices article, 23-99-414 in the health care provisions, and the Administrative Procedure Act at 25-15-203 and 25-15-204. Citing the rule rather than a generic reference to state law is what makes an Arkansas argument land as local.

For Arkansas practices

Run the value check before anything else. If the requested benefit is under $500, external review is not the route and the effort belongs elsewhere — a Department complaint, a corrected claim, or a direct conversation with the plan. Where the claim clears the threshold, the four months are generous by national standards, but the request still has to be complete: the Commissioner's one-business-day forwarding step assumes a request that is ready to go.

The physician's name has to be on the denial

Arkansas is one of the few states that refuses to let a denial stay anonymous. Under the Prior Authorization Transparency Act at Ark. Code 23-99-1111, an adverse determination on a prior-authorization request must be made by a physician holding a current, unrestricted Arkansas license issued by the State Medical Board.

Ark. Code 23-99-1115 then puts that physician on the page. The notice of adverse determination must carry the name, title and telephone number of the physician responsible for it, together with a number for peer-to-peer contact with another physician if the first is unavailable. The review entity must also provide a route by which a physician can ask that the request be reconsidered by a physician in the same specialty, in another appropriate specialty, or by a pharmacologist.

• A denial letter with no physician named is missing a statutory element.
• The peer-to-peer number is required, not a courtesy — ask for it in writing if it is absent.
• Specialty reassignment is available on request before the appeal is decided.